Month: September 2021

Live fireside chat with C. Russell Trenary, President and CEO of Outlook Therapeutics on Tuesday, September 28 at 2:00 PM ET ISELIN, N.J., Sept. 21, 2021 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced that C. Russell Trenary, President and Chief Executive Officer of Outlook Therapeutics, will participate in a fireside chat hosted by Kristen Kluska, Director, Equity Research at the Cantor Fitzgerald Virtual Global Healthcare Conference on Tuesday, September 28, 2021 at 2:00 PM ET. In addition to the fireside chat, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered...

VAN NUYS, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) — Eco Innovation Group, Inc. (OTC: ECOX) (“ECOX” or the “Company”), an innovative company aggregating investments in new technologies that promote environmental and social well-being and the advancement of green energy solutions, is proud to announce that it has now retired all remaining outstanding variable rate convertible debt from its balance sheet. This preemptive step follows similar steps taken over the summer as well as the Company’s pledge to retire remaining convertible notes and pursue non-dilutive future financing strategies. “In June, we noted we were actively pursuing a strategy to defend our shareholder friendly corporate ideal by eliminating potential sources of dilution,” noted ECOX CEO Julia Otey-Raudes. “We eliminated a large tranche of...

Purposeful features include adjustable cameras to connect easily with family and friends, HP GlamCam to make you look and feel your best on video calls, and HP Palette – a digital workspace software to simplify the creative processNews Highlight: HP Spectre x360 16 inch 2-in-1 Laptop PCPresent your best self with the HP Spectre x360 16 inch 2-in-1 Laptop PC, featuring a 5 MP IR camera, smart features that keep you in-frame and well-lit, and is the first HP consumer notebook made with recycled CNC aluminum.News Highlight: HP ENVY 34 inch All-in-One Desktop PCDesigned for creators by creators, the HP ENVY 34 inch All-in-One Desktop PC offers true-to-life color and a detachable magnetic camera for better angles or sharing sketches on your workspace.News Highlight: HP 11 inch Tablet PCExperience...

NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) — LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment, prescription medications, and over the counter products to patients across all 50 states today announced that management will present at the Cantor Fitzgerald Virtual Global Healthcare Conference. Details for the presentation are below:   Date: Thursday, September 30th, 2021Time: 12:40 pm ETWebcast: https://wsw.com/webcast/cantor12/lfmd/2065630   Management will also be available for virtual one-on-one meetings. To request a meeting, please contact corporateaccess@cantor.com. About LifeMDLifeMD, Inc. is a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment, prescription medications...

GUELPH, Ontario, Sept. 21, 2021 (GLOBE NEWSWIRE) — Current Water Technologies Inc. (TSX-V: WATR) (“CWTI” or “the Company” or “the Corporation”), an emerging technology leader in the management of industrial and municipal wastewater and drinking water resources, announced today that the Company has executed a Memorandum of Understanding (MOU) with a consortium of aquaculture companies collectively operating under the newly incorporated Canadian company, Ship Nature’s Way Inc. (SNW). A Definitive Collaboration Agreement with Ship Nature’s Way will be signed within the next 60 days. The global aquaculture market was valued at approximately USD230 billion in 2020, and the market is projected to grow to approximately USD340 billion in 2027, based on a predicted compound annual growth rate (CAGR) of...

London, UK, Sept. 21, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in two upcoming investor conferences as follows:            Maxim Group and M-Vest Mental Health Advances in Mental Health, Psychedelics and Non-Psychedelics Virtual Conference: “Clinics and Commercialization: Scaling psychedelics to meet the needs of the mental health space” and “Depression: Spravato opened the door – what comes next?” panels at 12:00pm and 2:00pm ET on September 22, 2021           Cantor Virtual Global Healthcare Conference: fireside chat at 10:40am ET on September 30, 2021Links to these webcasts will be available on the “Events” page of the Investors...

NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, M. Michelle Berrey, M.D., M.P.H., President of Research & Development and Chief Medical Officer of Intercept, Linda Richardson, Chief Commercial Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will present at the 2021 Cantor Virtual Global Healthcare Conference on Tuesday, September 28, 2021 at 8:40 a.m. ET. A live webcast of the event will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available...

Philanthropic Fund Expands DTM’s Corporate Giving Activities Company will Reactivate its Employee Volunteer Program DETROIT, Sept. 21, 2021 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) [www.dtmidstream.com], a premier natural gas pipeline, storage and gathering provider, today announced creation of a $2 million charitable fund as part of a wider effort to expand corporate giving activities in places where it does business and to further encourage employee volunteerism. “We’ve got the energy to achieve great things in communities where we live and work,” said David Slater, president and CEO, DT Midstream. “DTM’s charitable giving and volunteerism reinforces our company’s ESG (environmental, social and governance) goals and supports the charitable priorities of our employees and their communities.” DT Midstream will make contributions...

CALABASAS, Calif., Sept. 21, 2021 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application solutions provider, will hold a conference call on Tuesday, September 28, 2021 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the fiscal fourth quarter and full year ended June 30, 2021. Financial results will be issued in a press release prior to the call. NETSOL management will host the presentation, followed by a question-and-answer period. Date: Tuesday, September 28, 2021Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Toll-Free Dial-In: 877-407-0789International Dial-In: 201-689-8562 Please call the conference telephone number 10 minutes prior to the start time. An operator will register your name and organization. If you have any...

Patents Further Strengthen and Enhance Intellectual Property (IP) Portfolio CAMBRIDGE, Mass., Sept. 21, 2021 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the body, announced today the issuance of two new United States Patents Nos. 11,117,945 and 11,104,712 from the United States Patent and Trademark Office. U.S. Patent No. 11,117,945 covers Cue Biopharma’s first clinical drug candidate, CUE-101, and its use in treating HPV16-associated cancers such as head and neck, cervical, and genitoanal cancers. CUE-101 is currently in a Phase 1b clinical trial in which second line and beyond patients are receiving CUE-101 as a monotherapy for HPV16+ recurrent/metastatic head...